Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
2 clinical trials · 2 recruiting · OTHER
Trials by Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
RECRUITINGNCT07365930
NIS on the Benefits of TIPS in Patients With HCC Receiving Atezo+Bev in 1st-Line Therapy
The NISTIPS TRITICC-4 study is a prospective, multicentre, non-interventional cohort study to analyze the effectiveness of transjugular intrahepatic portosystemic shunting (TIPS)...
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestEnrolling: 3501 location
Hepatocellular Carcinoma (HCC)
RECRUITINGPhase 2NCT05713838
Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for...
The present clinical trial is a prospective, investigator-initiated, single-arm, open-label, multicenter phase II trial investigating whether a definite organ preservation therapy...
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestEnrolling: 3220 locations
Esophagus Adenocarcinoma